Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.  [electronic resource] 

 -  Circulation  Sep 1997 
 - 1445-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0009-7322 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.96.5.1445  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angina, Unstable--therapy<br/>Angioplasty, Balloon, Coronary<br/>Cardiovascular Diseases--drug therapy<br/>Coronary Artery Bypass<br/>Coronary Thrombosis--prevention & control<br/>Double-Blind Method<br/>Fibrinolytic Agents--therapeutic use<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--therapy<br/>Platelet Glycoprotein GPIb-IX Complex--antagonists & inhibitors<br/>Postoperative Complications--prevention & control<br/>Retreatment<br/>Time Factors<br/>Tirofiban<br/>Tyrosine--adverse effects